Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
“The world neeeeeeds leronlimab” well guess what? Leronlimab needs to not have a gah damn hold from the FDA to be relevant.
I do not know either of you but i disagree. News coming soon and let me tell you, i would not want to be short this one this month.
I agree! Very similar and those were tough times! Enjoy the ride - bulldog
HIV seems a long shot now. Check gileads PR from Friday regarding biktarvy. I think we missed the boat there. Oncology is the future as management pointed out on the call. Hopefully Covid revenue can help support that future and drive up sp in the meantime. Just my 2 cents. Fwiw, I’ve been long since Jan 2016, originally purchased shares at $1.15. Bought as low at $0.29 and as high as $7. Loaded more yesterday and today. I’m hopeful for a partnership with BP in the near future that will take leronlimab to the next level and give much needed credibility.
That’s powerful... Says a lot about the leadership team. Science speaks for itself, but I’m damn happy for Cytodyn to be lead by people of that kind of character. It will take us (and humanity) a looong ways.
Manufacturers are in the business of making money too, so I’d like to think we’d have other manufacturers lined up ready to make a deal. I’m not well versed in what that all entails, just my opinion.
@ohm, do you have any links or information i could pass along to the medical field relating to leronlimab and possible efficacy for auto immune diseases such as pulmonary sarcoidosis?
Where can this be viewed?
I think the company is in a much stronger position than they’ve ever been. Cash, massive catalysts, near term revenue, etc. I think they are being very careful with the combo BLA and taking time to make absolutely sure it’s “approvable”, and I believe they need to stay the course.
The stage has been set for a monster debut to the world in a few weeks. Many people here are too caught up in the day to day shenanigans to even see it.
Blew right through 3.56 resistance
I’m looking at the IMMU acquisition a little different than most here. I think it’s excellent for cydy as it validates the future of targeted oncology with mabs.
Don’t ever forget, the early bird gets the worm, but the second mouse gets the cheese.
Fwiw, IMMU’s BLA received a failure to file TWICE over the past 18 months. They finally were able to submit it and then received accelerated approval. This just goes to show that even if they paper work isn’t strong early on, the drug still prevailed.
Yet they still prescribe Tamiflu for mild to moderate flu symptoms by the tens of thousands. i see your rationale but respectfully disagree on this one Saltz.
HGEN stock is absolutely anemic. Considered buying back in a week or so ago but damn.. no liquidity at all. Reinforces my hold here on cydy (long since Jan 2015)
Up 9% pre market
For what it’s worth, i know over a dozen shareholders with 25k-200k shares (obviously not whales nor small guys either) that have held this stock for 5+ years and never read a message board in their life. I’m sure there’s a lot more that fit into this same category.
Feel like HGEN has a ton of potential. Am looking to buy back in at these Cheap prices but I’d like some clarification on a couple things...
A. What’s the situation with uplist to NASDAQ?
B. Why such low trading volume?
C. What is timeline on potential fda EUA?
I’m long CYDY and have traded in and out of HGEN but am looking to diversify and firmly believe MABS are the therapeutic solution to COVID. I don’t think any one drug has the efficacy for all patients nor the ability to manufacture to scale.
Well said. Likewise. Averaged up to $.97 yesterday
Try sending Nader an email. He responds from his phone.
That pretty big man..wow
Article may be old but new acquisition is coming
Actually it’s a new acquisition should be announced this week
I think people have become immune to leronlimab’s safety profile. It really is something spectacular that no other Covid (or any other disease) therapeutic can claim.
Great article. Thanks for sharing
You bet
From Fred on another board:
Been here and seen this.
I was a long timer in IMMU (5 years), recently moved over to CYDY. So thought I would share some of the things we saw go on there.
AF attacked us several times, we had multiple days like what we saw here on 30 June but we hung in there and finally made it to approval. I was with you all on Jun 30th and was just as disappointed as you all were.
At IMMU we had a trial stopped for efficacy on April 6 2020, I have tried to find what date the DSMC board actually met but I didn't find it, probably need to dig deeper. It took until 22 April for us to get approval from the FDA.
So if they stop this trial for efficacy don't expect to get an immediate EAU.
Not bashing, or raining on any parades just passing on what I have experienced.
I'm here for the duration and won't be driven away because I have already been there and seen this before. The science will win through.
If Cytodyn is valued at $2.5B pre revenue and pre approved drug, imagine what it’ll be after 1st Covid approval. Wow
New investor here. Can someone give me the highlights on upcoming catalysts?
Anyone have a link to a good MEDICAL article explaining leronlimab and it’s MOA? Trying to edumacate a local Dr
By stopping trial, would that effectively be an approval as it works so much better than placebo it’s deemed unethical to continue giving placebo?
Agree.. I cringed when he mentioned shorts on that call. I did however find a soft spot in my heart when he said “attack me, not leronlimab”. That was the silver lining for me.
That was not directed at you, just a response to tour message and call to action. I take the BS spewed on this board with a grain of salt. I’ve been invested and studying this company and molecule for 4+ years. Some newbie from last month isn’t going to change my mind about what I’ve learned, understand, and know about Leronlimab.
If you don’t think Leronlimab will be standard of care by September/October, you’re off your rocker. US gov will throw so much money at it, scaling up manufacturing won’t be an issue at all. We need people OUT of the hospitals and Leronlimab is the closest (and most effective) therapeutic to making that happen. Vaccines are a long way from being proven and only many years’ time will tell the long term effect it will have on humans. I for one, will not be taking a Covid vaccine no matter what the media says about it.
I thought on the cc that they confirmed the symbol would stay cydy. Did i dream that up?
We believe the significant reduction in SAEs in the leronlimab group ultimately translates into improved patient clinical outcomes.
Prior drugs in clinical trials for the treatment of COVID-19 have resulted in an increase in SAEs in the drug treated arm versus placebo. We are extremely proud of these results.”
98.81% survival rate........
Assuming fantastic results tomorrow and where competitors are in trials now, how valuable is it that we already have manufacturing and distribution partners in place? That has to be huge right?
None have contracted Covid. CEO stated that Saturday evening. If they had contracted Covid, cytodyn would be notified immediately.